Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells

The New England Journal of Medicine
B F HaynesP A Bunn

Abstract

We studied the surface-antigen pattern of T cells in peripheral blood and cell lines from patients with advanced cutaneous T-cell lymphoma (CTCL) or T-cell acute lymphoblastic leukemia. The antigen patterns of cutaneous T-cell lymphoma cells from peripheral blood and established cell lines were nearly identical; the cells were negative for human thymus antigen (OKT6 and NA1/34), positive for pan-T-cell (OKT3, 17F12, 10.2, and 9.6) and helper-T-cell-subset (OKT4) antigens, and negative for T-cell-subset antigens 3A1 and OKT8. In contrast, the phenotypes of malignant T cells from patients with acute lymphoblastic leukemia were heterogeneous, with at least five patterns of reactivity. The T-cell-specific antibody 3A1 was the only monoclonal reagent that clearly distinguished the peripheral-blood T cells in CTCL (3A1-) from those in acute lymphoblastic leukemia (3A1+). Moreover, 3A1 was the most reliable T-cell marker in acute lymphoblastic leukemia. We conclude that circulating CTCL (Sézary) T cells are homogeneous in their antigen phenotype and are derived from a well-differentiated 3A1-, OKT4+, OKT8- helper-T-cell subset.

References

Dec 1, 1976·The Journal of Clinical Investigation·S BroderT A Waldmann
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·B F HaynesA S Fauci
Mar 1, 1979·European Journal of Immunology·A J McMichaelC Milstein
May 1, 1974·Journal of the National Cancer Institute·T MohanakumarD S Miller
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·B F HaynesA S Fauci
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Jan 1, 1981·The Journal of Experimental Medicine·M KamounR C Nowinski
Feb 1, 1981·The Journal of Clinical Investigation·B F HaynesA S Fauci
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·E G EnglemanR Levy
Jan 1, 1981·Immunological Reviews·B F Haynes

❮ Previous
Next ❯

Citations

Dec 1, 1994·American Journal of Hematology·M AdachiA Yachi
Jan 1, 1983·Archives of Dermatological Research·K MeissnerM Jänner
Aug 1, 1988·Biulleten' eksperimental'noĭ biologii i meditsiny·O V KorotkovaA M Novikov
Mar 1, 1987·Journal of Clinical Immunology·D F Lobach, B F Haynes
Feb 1, 1986·Italian Journal of Neurological Sciences·R RocchiM Fimiani
Jan 6, 1989·Journal of Immunological Methods·L K Jung, S M Fu
Oct 1, 1988·Immunology Letters·S H FengA C Wang
Oct 28, 1986·Biochimica Et Biophysica Acta·C L Reading, Y Takaue
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U Reinhold, H Abken
May 1, 1982·Lancet·M E Kadin, M Kamoun
Feb 1, 1982·Journal of the American Academy of Dermatology·C M Lapiere
Dec 1, 1995·Blood Reviews·S H KroftL C Peterson
Feb 13, 2001·The British Journal of Dermatology·M G BernengoM T Fierro
Sep 5, 2002·The British Journal of Dermatology·H-H ChenH-C Chiu
Oct 1, 1981·The New England Journal of Medicine·M De WaeleB Van Camp
Apr 1, 1982·The New England Journal of Medicine·R A JacksonG S Eisenbarth
Aug 29, 1985·The New England Journal of Medicine·V BertnessP A Bunn
Aug 11, 2000·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·J SciubbaJ Fantasia
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R UedaK Ota
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J LeW Prensky
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B F HaynesR S Metzgar
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M P DaveyT A Waldmann
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S M DenningB F Haynes
May 10, 2011·The American Journal of Dermatopathology·Chris H JokinenHarvey A Greisman
May 1, 1996·The British Journal of Dermatology·C CollenbergM S Gruschwitz
Oct 1, 1991·British Journal of Haematology·A Z Rohatiner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.